Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Yung Shin Pharmaceutical Industrial Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include active pharmaceutical ingredients, traditional Chinese medicine, human medicine, animal medicine, food products, and medical equipment. The company was founded by Tien Te Li in 1952 and is headquartered in Taichung, Taiwan.

Suzhou Taifeier Pharmaceutical Co., Ltd., established on 2010-08-31, Business scope includes research and development of pharmaceutical intermediates,Sales;new medical research;Medical technology service and technology transfer(The above involves licensing,Operate only after obtaining a license);Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.

Manufactures and sells pharmaceutical products

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Zhangjiagang Xinyi Chemical Co., Ltd., established on 1998-09-22, The scope of business includes the purchase and sale of chemical raw materials and products;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Anhui Qingyun Pharmaceutical Co., Ltd., established on 2003-08-26, Business scope includes raw materials(Amlexanox,pitavastatin calcium,Rosuvastatin Calcium)Production,Sales;Fine Chemicals(Does not contain dangerous goods)Research,to develop,Production,Sales;medicine,Pharmaceutical and chemical products(law,Except as stipulated by regulations)Development,to develop,Technical consultation and service,Daily necessities,hardware tools,Chemical machinery,Instrument and equipment sales.(Operate within the validity period of the license)

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Nippon Chemiphar Co., Ltd. engages in the healthcare business. It manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents. It operates through the Pharmaceuticals and Others segments. The Pharmaceuticals segment manufactures and sells prescription drugs. The Others segment includes safety testing consignment, healthcare, and real estate businesses. The company was founded by Akira Yamaguchi on June 16, 1950 and is headquartered in Tokyo, Japan.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Nitto Denko Corp. engages in the manufacture and sale of adhesives, optical films, semiconductors, electronic devices, and consumer products. It operates through the following segments: Industrial Tape, Optronics, Human Life, and Others. The Industrial Tape segment deals with the manufacture and sale of sealing, protective, process, and automotive materials. The Optronics segment offers optical films, printed circuits, and high-precision substrates. The Human Life segment handles the manufacturing services for nucleic acids, nucleic acid synthesis materials, and medical-related materials. The Others segment includes new businesses. The company was founded on October 25, 1918 and is headquartered in Osaka, Japan.

Part of Tris Pharma, Inc., Park Therapeutics, Inc. is a company headquartered in Morristown, NJ, that develops drugs for treatment of pain. The firm was founded by Marc L. Lesnick and James Hackworth. James Hackworth is currently the CEO of the company. On April 29, 2021 Tris Pharma, Inc. acquired Park Therapeutics, Inc.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.

Hangzhou Dick Technology Co., Ltd., established on 2018-12-25, Business scope includes wholesale,retail:Chemical products and raw materials(In addition to chemical dangerous goods and the first category of precursor chemicals);Serve:Fine chemical intermediates and chemical products,modern agricultural technology,Environmental Engineering Technology Development,technical consulting,Achievement transfer(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)